| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |